Fusitrend-C Cream is a topical medication combining Clobetasol propionate (0.05% w/w), a potent corticosteroid, with Fusidic Acid (2.00% w/w), a bacteriostatic antibiotic, designed to treat inflammatory skin conditions complicated by bacterial infections. Clobetasol effectively reduces inflammation, redness, and itching by suppressing the immune response in affected skin areas, making it suitable for conditions such as eczema, psoriasis, and dermatitis. Fusidic Acid targets and inhibits the growth of susceptible bacteria, particularly Staphylococcus aureus, helping to prevent or treat secondary bacterial infections that often accompany inflammatory dermatoses. The synergistic action of these two active ingredients provides both anti-inflammatory and antibacterial benefits, promoting faster healing and symptom relief. Fusitrend-C Cream is typically applied in a thin layer to the affected area once or twice daily, as directed by a healthcare professional, and should not be used on large areas or for prolonged periods to avoid potential side effects such as skin thinning or systemic absorption of corticosteroids. It is important to avoid contact with eyes and mucous membranes. This combination therapy is ideal for patients requiring both anti-inflammatory and antibacterial treatment in a single formulation, ensuring convenience and improved compliance.